PISTELLO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 18.878
EU - Europa 9.007
AS - Asia 5.502
AF - Africa 532
SA - Sud America 258
OC - Oceania 195
Continente sconosciuto - Info sul continente non disponibili 3
Totale 34.375
Nazione #
US - Stati Uniti d'America 18.199
IT - Italia 3.267
CN - Cina 2.401
SE - Svezia 1.555
SG - Singapore 948
DE - Germania 940
BG - Bulgaria 787
GB - Regno Unito 660
CA - Canada 581
TR - Turchia 550
UA - Ucraina 438
VN - Vietnam 314
FI - Finlandia 276
RU - Federazione Russa 253
CI - Costa d'Avorio 207
ID - Indonesia 205
CH - Svizzera 194
BR - Brasile 185
AU - Australia 167
IN - India 167
PH - Filippine 119
HK - Hong Kong 115
AT - Austria 114
FR - Francia 105
IR - Iran 98
KR - Corea 98
PK - Pakistan 85
SN - Senegal 84
NG - Nigeria 79
BE - Belgio 72
MX - Messico 67
IQ - Iraq 66
MY - Malesia 60
EG - Egitto 59
JP - Giappone 59
NL - Olanda 48
SA - Arabia Saudita 45
IE - Irlanda 40
RO - Romania 40
ES - Italia 36
TW - Taiwan 35
NZ - Nuova Zelanda 28
CZ - Repubblica Ceca 27
PT - Portogallo 25
TH - Thailandia 22
BD - Bangladesh 21
HU - Ungheria 20
KE - Kenya 19
AR - Argentina 18
CO - Colombia 18
LK - Sri Lanka 18
PL - Polonia 18
ZA - Sudafrica 18
GH - Ghana 16
GR - Grecia 16
AE - Emirati Arabi Uniti 13
CL - Cile 12
IL - Israele 12
BS - Bahamas 11
EC - Ecuador 11
SK - Slovacchia (Repubblica Slovacca) 11
ET - Etiopia 10
SI - Slovenia 10
DZ - Algeria 9
NO - Norvegia 8
BJ - Benin 7
HR - Croazia 7
LT - Lituania 7
PE - Perù 7
TN - Tunisia 7
CR - Costa Rica 6
LB - Libano 6
BO - Bolivia 5
DK - Danimarca 5
HN - Honduras 5
JO - Giordania 5
LV - Lettonia 5
MA - Marocco 5
NP - Nepal 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
MO - Macao, regione amministrativa speciale della Cina 4
PS - Palestinian Territory 4
YE - Yemen 4
IM - Isola di Man 3
KH - Cambogia 3
MD - Moldavia 3
OM - Oman 3
PR - Porto Rico 3
UG - Uganda 3
AL - Albania 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
MN - Mongolia 2
Totale 34.350
Città #
Woodbridge 2.206
Ann Arbor 1.646
Fairfield 1.601
Houston 1.544
Chandler 1.396
Santa Clara 1.332
Ashburn 881
Milan 826
Sofia 783
Shanghai 719
Seattle 690
Wilmington 600
Jacksonville 577
Serra 542
New York 512
Cambridge 502
Beijing 499
Singapore 480
Ottawa 450
Princeton 409
Boardman 374
Lawrence 308
Izmir 306
Medford 278
Nanjing 264
Florence 241
Abidjan 207
Des Moines 179
Bern 168
Pisa 161
Dearborn 152
Istanbul 149
San Diego 128
Dong Ket 116
Redwood City 111
Vienna 108
Jüchen 104
Nanchang 94
Rome 94
London 92
Dakar 84
Lancaster 80
Hong Kong 70
Bremen 68
Guangzhou 68
Los Angeles 68
Lagos 58
Brussels 57
Hebei 56
Shenyang 55
Kunming 52
Frankfurt am Main 51
Washington 48
Falls Church 46
Jakarta 46
Ogden 46
Fuzhou 38
Changsha 37
Jiaxing 37
Hangzhou 36
Norwalk 36
Ankara 34
Brisbane 34
Columbus 34
Durham 34
Toronto 34
Boulder 33
Sydney 33
Melbourne 32
Hefei 31
Pune 31
Düsseldorf 30
Livorno 27
Phoenix 25
Sohag 25
Helsinki 24
Jinan 24
San Francisco 24
Cascina 23
Manchester 23
Orange 23
Grosseto 22
Tianjin 22
Najaf 21
Quanzhou 21
Tehran 21
Dublin 20
Karachi 20
Tokyo 20
Chicago 19
Bucharest 18
Dallas 18
Indianapolis 18
Rivalta di Torino 18
Paris 17
Surabaya 17
Auburn Hills 16
Brno 16
Southborough 16
Verona 16
Totale 23.900
Nome #
Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies 2.734
Viral vectors: a look back and ahead on gene transfer technology 816
Evolution of viruses and the emergence of SARS-CoV-2 variants 212
Accertamenti sierologici in gatti a rischio per infezione da FIV (Feline Immunodeficiency Virus) 199
AN ECO RI RESTRICTION LENGTH POLYMORPHISM AT THE MURINE L-MYC LOCUS 173
ACTIVATION BY POINT MUTATION OF KI-RAS GENE OCCURRING IN TRANSFECTED HUMAN NORMAL DNA 170
Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus 167
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts 166
NUCLEAR ONCOGENE AMPLIFICATION OR REARRANGEMENT IS NOT INVOLVED IN HUMAN COLORECTAL MALIGNANCIES 163
The Novel Anellovirus SAV is Highly Prevalent in hepatitis C patients and healthy controls and as Diverse as the Other Two Species of the Genus, TTV and TTMV 161
Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes 161
Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1 161
Induced pluripotent stem cells in hematology: current and future applications. 153
Cyclovirus Vietnam DNA in immunodeficient patients 153
P24 Major core-antigen in renal tissue of Feline Immunodeficiency (FIV) infected cats with renal damage 152
Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B 151
Torque teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplant. 151
Renal involvement in Feline Immunodeficiency Virus infection: p24 antigen detection, virus isolation and PCR analysis 149
Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties 149
Detection of feline immunodeficiency virus RNA by two nucleic acid sequence based amplification (NASBA) formats 149
Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA 148
Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine 148
Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats 148
MALIGNANT-LYMPHOMA ASSOCIATED WITH EXPERIMENTALLY-INDUCED FELINE IMMUNODEFICIENCY VIRUS-INFECTION 145
Low-dose interferon-alpha treatment for feline immunodeficiency virus infection 144
Immunogenicity of a fixed cell FIV vaccine in field cats 144
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients 144
A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma 144
Feline immunodeficiency virus vector as a tool for preventative strategies against human breast cancer 143
Acid sensitivity of cell-free and cell-associated HIV-1: Clinical implications 143
Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells 143
A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein 143
Feline immunodeficiency virus (FIV) genome in peripheral blood mononuclear cells of FIV-seronegative cats 142
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9 142
AIDS Vaccination Studies with an Ex Vivo Feline Immunodeficiency Virus Model: Analysis of the Accessory ORF-A Protein and DNA as Protective Immunogens 142
A nosocomial measles outbreak in Italy, February-April 2017 141
Estimating population parameters by allele frequency distribution of minisatellite hypervariable loci 140
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients 140
AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viral replication following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus 139
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 139
Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors 138
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 137
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates 136
La saliva come sostituto del siero nella diagnosi di laboratorio dell'infezione da FIV 135
Distribution of variable number of tandem repeat (VNTR) DNA polymorphism at D2S44 locus in Tuscany (Italy). 135
Torque Teno virus: any pathological role in liver transplanted patients? 135
Accertamenti sierologici e virologici in gatti a rischio per l'infezione da FIV (Feline Immunodeficiency Virus) 134
THE INFLUENCE OF CELL-CULTURE AND STORAGE-CONDITIONS ON HIV-1 INFECTIVITY AND FUSOGENIC ACTIVITY 134
PREVALENCE OF HEPATITIS-C VIRUS GENOTYPES IN ITALY 134
Does lung microbiome play a causal or casual role in asthma? 134
No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan 134
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats 133
PARTIAL NUCLEOTIDE SEQUENCING OF 6 SUBTYPE 2C HEPATITIS-C VIRUSES DETECTED IN ITALY 132
TRANSFORMING ACTIVITY OF NORMAL HUMAN DNA MANIFESTED USING NIH-3T3 TRANSFECTION ASSAY 131
Accertamenti sierologici e virologici in gatti a rischio per infezione da FIV (Feline Immunodeficiency Virus). 131
Development Of A Self-Inactivating Bicistronic Lentiviral Vector For Heterologous Primary Cells Transduction, 131
Distribution of variable number of tandem repeat (VNTR) DNA polymorphism at D2S44 locus in Tuscany (Italy). 130
COMPETITIVE POLYMERASE CHAIN-REACTION FOR QUANTITATING FELINE IMMUNODEFICIENCY VIRUS LOAD IN INFECTED CAT TISSUES 129
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha 2 therapy 129
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 129
Viral hepatitis 126
Neuropathogenic potential of ORF-A truncated mutants of FIV-Petaluma 125
Prime-Boost Vaccination with DNA-Transduced Autologous Lymphocytes Protects Against Fully Virulent Homologous Challenge in the Feline Immunodeficiency Virus AIDS Model 125
Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro 125
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy 124
A dormant internal ribosome entry site controls translation of feline immunodeficiency virus 124
La saliva come sotituto del siero nella diagnosi di laboratorio dell'infezione da FIV 123
Pre-infection with a poorly pathogenic FIV does not prevent infection by a fully virulent heterologous strain 123
In vivo Delivery of Herpes Simplex Type 1 Glycoprotein B Confers Substantial Protection against Genital Herpes 123
Env-Expressing Autologous T Lymphocytes Induce Neutralizing Antibody and Afford Marked Protection against Feline Immunodeficiency Virus 123
Identification of coronaviruses in dogs that segregate separately from the canine coronavirus genotype 123
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction 122
Unsung Hero Robert C. Gallo 122
Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions 122
Hepatitis viruses 121
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 121
Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-Cell subsets in blood 119
Utility of combination therapy with ribavirin plus interferon on chronic hepatitis C patients previously resistant to interferon. 117
Monitoring Human Immune Competence Using a Symbiont Virus: From Bench to Bedside 117
SEROLOGICAL REACTIVITY AND VIRAL GENOTYPES IN HEPATITIS-C VIRUS-INFECTION 116
Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1 infected patients 116
How the recently accomplished complete sequencing and annotation of the domestic cat genome can benefit basic AIDS research carried out with feline immunodeficiency 116
Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution 116
Identification of a novel HLA-DRB1*11 variant allele, DRB1*1189 115
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 115
Renal alterations in feline Immunodeficiency Virus (FIV)- Infected cats : a possible natural model of lentivirus-Induced renal disease changes 115
COMPARISON BETWEEN HEPATITIS-C VIRUS GENOTYPE AND RESPONSE TO ALPHA-INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C 114
Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region 114
Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: Different ways to counteract host-encoded restriction 114
null 114
A NEUTRALIZING ANTIBODY-INDUCING PEPTIDE OF THE V3 DOMAIN OF FELINE IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN DOES NOT INDUCE PROTECTIVE IMMUNITY 113
The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry 113
Detection and in vivo localization of feline immunideficiency provirus by PCR in situ hybridization 112
Tumor necrosis factor-alpha expression in CNS of FIV infected cats 112
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host Health 112
Prevalence and loads of torquetenovirus (TTV) in the European MARK-AGE Study population 112
Human Neural Stem Cell Systems to Explore Pathogen-Related Neurodevelopmental and Neurodegenerative Disorders 112
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model 112
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection 112
Feline immunodeficiency virus (FIV) infection in cats: a possible cause of renal pathological changes 111
Totale 16.724
Categoria #
all - tutte 96.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.137 0 0 0 0 0 0 512 350 475 287 440 73
2020/20212.643 237 110 226 107 249 126 182 267 261 261 165 452
2021/20224.583 154 291 120 335 703 512 373 264 216 175 328 1.112
2022/20234.726 617 583 331 444 524 605 91 284 763 33 394 57
2023/20245.215 502 416 572 380 693 755 356 337 185 265 318 436
2024/20254.598 160 517 211 805 1.212 1.182 511 0 0 0 0 0
Totale 35.100